mk 767 has been researched along with thiazoles in 12 studies
| Studies (mk 767) | Trials (mk 767) | Recent Studies (post-2010) (mk 767) | Studies (thiazoles) | Trials (thiazoles) | Recent Studies (post-2010) (thiazoles) |
|---|---|---|---|---|---|
| 32 | 0 | 10 | 33,179 | 2,100 | 12,330 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 8 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akanuma, Y; Ide, T; Kadowaki, T; Mochizuki, T; Murakami, K; Ohashi, M; Tobe, K; Yazaki, Y | 1 |
| Awano, K; Kinoshita, S; Maeda, T; Miyachi, H; Murakami, K; Nomura, M; Satoh, H; Tsunoda, M | 1 |
| Ide, T; Kadowaki, T; Mochizuki, T; Murakami, K; Suzuki, M | 1 |
| Ide, T; Mochizuki, T; Murakami, K; Ohashi, M; Tsunoda, M | 1 |
| Ide, T; Mochizuki, T; Murakami, K; Nakazawa, T | 1 |
| Chaput, E; Edgar, AD; Saladin, R; Silvestre, M | 1 |
| Ide, T; Kadowaki, T; Mochizuki, T; Murakami, K; Nakazawa, T; Okazaki, T | 1 |
| Yamanouchi, T | 1 |
| Fujita, H; Hirose, H; Kawai, T; Miyashita, K; Ogawa, T; Saruta, T; Seto, Y; Ukeda, K; Yajima, K; Yamada, T; Yamamoto, Y | 1 |
| Calkin, AC; Cooper, ME; Thomas, MC | 1 |
| Narce, M; Poisson, JP | 1 |
| Miyachi, H | 1 |
3 review(s) available for mk 767 and thiazoles
| Article | Year |
|---|---|
[KRP-297, MCC-555].
Topics: Animals; Clinical Trials, Phase II as Topic; Diabetes Mellitus; Glucose; Humans; Hypoglycemic Agents; Lipid Metabolism; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Thiazolidines; Transcription Factors | 2001 |
MK-767. Kyorin/Banyu/Merck.
Topics: Animals; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Contraindications; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Thiazoles; Thiazolidines | 2003 |
[Design and synthesis of subtype- and species-selective peroxisome proliferator-activated receptor (PPAR) alpha ligands].
Topics: Animals; Drug Design; Humans; Phenylpropionates; PPAR alpha; Species Specificity; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Thiazolidines | 2004 |
9 other study(ies) available for mk 767 and thiazoles
| Article | Year |
|---|---|
A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats.
Topics: Acyl-CoA Oxidase; Adipose Tissue; Animals; Blood Glucose; Body Weight; Carrier Proteins; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; Fatty Acids; Gene Expression; Hypoglycemic Agents; Insulin; Ligands; Lipid Metabolism; Liver; Male; Myelin P2 Protein; Neoplasm Proteins; Nerve Tissue Proteins; Obesity; Organ Size; Oxidoreductases; Radioligand Assay; Rats; Rats, Wistar; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Thiazolidines; Transcription Factors; Transcriptional Activation; Triglycerides | 1998 |
(3-substituted benzyl)thiazolidine-2,4-diones as structurally new antihyperglycemic agents.
Topics: Animals; Blood Glucose; Hypoglycemic Agents; Insulin; Mice; Mice, Obese; Pioglitazone; Structure-Activity Relationship; Thiazoles; Thiazolidinediones; Thiazolidines; Triglycerides | 1999 |
Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor alpha.
Topics: Animals; Binding, Competitive; CHO Cells; Cricetinae; Eicosanoids; Fatty Acids; Fatty Acids, Unsaturated; Gene Expression Regulation; Genes, Reporter; Humans; Hydroxyeicosatetraenoic Acids; Inhibitory Concentration 50; Kinetics; Ligands; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidines; Transcription Factors; Transfection | 1999 |
Amelioration by KRP-297, a new thiazolidinedione, of impaired glucose uptake in skeletal muscle from obese insulin-resistant animals.
Topics: Animals; Blood Glucose; Glucose; Hypoglycemic Agents; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Obesity; Thiazoles; Thiazolidines | 1999 |
Tissue-specific actions of antidiabetic thiazolidinediones on the reduced fatty acid oxidation in skeletal muscle and liver of Zucker diabetic fatty rats.
Topics: Administration, Oral; Animals; Chromans; Diabetes Mellitus; Fatty Acids; Hypoglycemic Agents; Liver; Male; Muscle, Skeletal; Obesity; Oxidation-Reduction; Palmitic Acid; Rats; Rats, Zucker; Reference Values; Substrate Specificity; Thiazoles; Thiazolidinediones; Thiazolidines; Triglycerides; Troglitazone | 2000 |
Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight.
Topics: Acyl-CoA Oxidase; Animals; Apolipoprotein A-I; Apolipoprotein C-III; Apolipoproteins C; Body Weight; Carrier Proteins; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; Fenofibrate; Hypolipidemic Agents; Male; Mice; Myelin P2 Protein; Neoplasm Proteins; Nerve Tissue Proteins; Oxidoreductases; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Thiazolidines; Time Factors; Transcription Factors; Triglycerides | 2000 |
Fatty-acyl-CoA thioesters inhibit recruitment of steroid receptor co-activator 1 to alpha and gamma isoforms of peroxisome-proliferator-activated receptors by competing with agonists.
Topics: Acyl Coenzyme A; Animals; Binding, Competitive; Fatty Acids; Histone Acetyltransferases; Ligands; Liver; Male; Muscles; Nuclear Receptor Coactivator 1; Plasmids; Protein Isoforms; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Thiazoles; Thiazolidines; Transcription Factors; Tritium | 2001 |
Combination therapy with PPARgamma and PPARalpha agonists increases glucose-stimulated insulin secretion in db/db mice.
Topics: Animals; Bezafibrate; Body Weight; Diabetes Mellitus; Drug Therapy, Combination; Glucose; Glucose Transporter Type 2; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Monosaccharide Transport Proteins; Pancreas; Pioglitazone; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Thiazolidines; Transcription Factors | 2003 |
Novel PPARgamma-dependent and independent effects for thiazolidinediones.
Topics: Animals; Bezafibrate; Body Weight; Chromans; Diabetes Mellitus, Type 2; Gene Expression; Humans; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Proteins; Mice; Monocytes; Pancreas; Pioglitazone; PPAR alpha; PPAR gamma; Pregnancy Proteins; Pregnane X Receptor; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Rosiglitazone; Thiazoles; Thiazolidinediones; Thiazolidines; Troglitazone; Tumor Necrosis Factor-alpha | 2003 |